Behçet Syndrome in Children

  • Emire Seyahi
  • Isabelle Koné-Paut


Behçet syndrome (BS) may be occasionally seen in children; its frequency ranges between 4 and 26% among the whole BS population. Genders are equally affected, and familial cases are more frequent than in adult patients. The mean age of onset is around 8 years, but the disease is generally recognized later (3–5 years). While erythema nodosum is more prevalent among those with prepubertal onset, genital ulcers develop more frequently after puberty. Skin mucosa lesions and vascular disease are less frequent, while neurological disease is more common among pediatric patients compared to the adults. Despite its low frequency, large vessel disease is still severe and is the main cause of mortality. Dural sinus thrombosis is the dominating type of neurological disease. Genetic conditions mimicking BS may be misleading and investigated particularly in this age group, especially in patients with familial history, recurrent fevers with elevated acute phase reactants, and prominent colitis. Similar to what is observed in adults, disease runs significantly more severe course among boys with regard to morbidity and mortality.


Pediatric Behçet syndrome Juvenile Behçet syndrome Children, puberty Family history Genetics 


  1. 1.
    Kural-Seyahi E, Fresko I, Seyahi N, et al. The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore). 2003;82:60–76.CrossRefGoogle Scholar
  2. 2.
    Shafaie N, Shahram F, Davatchi F, et al. Behçet’s disease in children. In: Wechsler B, Godeau P, editors. Behçet’s disease. Amsterdam: Excerpta Medica; 1993. p. 381–3.Google Scholar
  3. 3.
    Hamza M. Juvenile Behçet’s disease. In: Wechsler B, Odeau PG, editors. Behçet’s disease. Amsterdam: Excerpta Medica; 1993. p. 377–80.Google Scholar
  4. 4.
    Kim DK, Chang SN, Bang D, Lee ES, Lee S. Clinical analysis of 40 cases of childhood-onset Behçet’s disease. Pediatr Dermatol. 1994;11:95–101.PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Bahabri SA, al-Mazyed A, al-Balaa S, el-Ramahi L, al-Dalaan A. Juvenile Behçet’s disease in Arab children. Clin Exp Rheumatol. 1996;14:331–5.PubMedGoogle Scholar
  6. 6.
    Sarica R, Azizlerli G, Köse A, Dişçi R, Ovül C, Kural Z. Juvenile Behçet’s disease among 1784 Turkish Behçet’s patients. Int J Dermatol. 1996;35:109–11.PubMedCrossRefPubMedCentralGoogle Scholar
  7. 7.
    Fujikawa S, Suemitsu T. Behçet disease in children: a nationwide retrospective survey in Japan. Acta Paediatr Jpn. 1997;39:285–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Vaiopoulos G, Kaklamani VG, Markomichelakis N, Tzonou A, Mavrikakis M, Kaklamanis P. Clinical features of juvenile Adamantiades-Behçet’s disease in Greece. Clin Exp Rheumatol. 1999;17:256–9.PubMedPubMedCentralGoogle Scholar
  9. 9.
    Krause I, Uziel Y, Guedj D, et al. Childhood Behçet’s disease: clinical features and comparison with adult-onset disease. Rheumatology (Oxford). 1999;38:457–62.CrossRefGoogle Scholar
  10. 10.
    Treudler R, Orfanos CE, Zouboulis CC. Twenty-eight cases of juvenile-onset Adamantiades-Behçet disease in Germany. Dermatology. 1999;199:15–9.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Koné-Paut I, Gorchakoff-Molinas A, Weschler B, Touitou I. Paediatric Behçet’s disease in France. Ann Rheum Dis. 2002;61:655–6.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Seyahi E, Ozdogan H, Uğurlu S, et al. The outcome children with Behçet’s syndrome. Clin Exp Rheumatol. 2004;22(4 :Suppl 34):116.Google Scholar
  13. 13.
    Karincaoglu Y, Borlu M, Toker SC, et al. Demographic and clinical properties of juvenile-onset Behçet’s disease: a controlled multicenter study. J Am Acad Dermatol. 2008;58:579–84.PubMedCrossRefGoogle Scholar
  14. 14.
    Koné-Paut I, Shahram F, Darce-Bello M, Cantarini L, Cimaz R, Gattorno M, et al. Consensus classification criteria for paediatric Behçet’s disease from a prospective observational cohort: PEDBD. Ann Rheum Dis. 2016;75:958–64.PubMedCrossRefGoogle Scholar
  15. 15.
    International Study Group for Behcet’s Disease. Criteria for diagnosis of Behçet’s disease. Lancet. 1990;335:1078–80.Google Scholar
  16. 16.
    Koné-Paut I, Bernard JL. Behçet’s disease in children: a French nationwide survey. Arch Fr Pediatr. 1993;50:145–54.PubMedGoogle Scholar
  17. 17.
    Ozen S, Karaaslan Y, Ozdemir O, et al. Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study. J Rheumatol. 1998;25:2445–9.PubMedGoogle Scholar
  18. 18.
    Yazici H, Biyikli M, van der Linden S, Schouten HJ. The ‘zero patient’ design to compare the prevalences of rare diseases. Rheumatology (Oxford). 2001;40:121–2.CrossRefGoogle Scholar
  19. 19.
    Koné-Paut I, Geisler I, Wechsler B, Ozen S, Ozdogan H, Rozenbaum M, Touitou I. Familial aggregation in Behçet’s disease: high frequency in siblings and parents of pediatric probands. J Pediatr. 1999;135:89–93.CrossRefGoogle Scholar
  20. 20.
    Borlu M, Ukşal U, Ferahbaş A, Evereklioglu C. Clinical features of Behçet’s disease in children. Int J Dermatol. 2006;45:713–6.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Gül A. Pathogenesis of Behçet’s disease: autoinflammatory features and beyond. Semin Immunopathol. 2015;37:413–8.CrossRefGoogle Scholar
  22. 22.
    Gül A. Behçet’s disease: an update on the pathogenesis. Clin Exp Rheumatol. 2001;19(5 Suppl 24):S6–12.Google Scholar
  23. 23.
    Gül A, Inanç M, Ocal L, Aral O, Koniçe M. Familial aggregation of Behçet’s disease in Turkey. Ann Rheum Dis. 2000;59:622–5.PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Fresko I, Soy M, Hamuryudan V, et al. Genetic anticipation in Behçet’s syndrome. Ann Rheum Dis. 1998;57:45–8.PubMedPubMedCentralGoogle Scholar
  25. 25.
    Molinari N, Koné Paut I, Manna R, Demaille J, Daures JP, Touitou I. Identification of an autosomal recessive mode of inheritance in paediatric Behçet’s families by segregation analysis. Am J Med Genet A. 2003;122A(2):115–8.PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Okuzaki D, Yoshizaki K, Tanaka T, Hirano T, Fukushima K, Washio T, Nojima H. Microarray and whole-exome sequencing analysis of familial Behçet’s disease patients. Sci Rep. 2016;6:19456.PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Stark AC, Bhakta B, Chamberlain MA, Dear P, Taylor PV. Life-threatening transient neonatal Behçet’s disease. Br J Rheumatol. 1997;36:700–2.PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    Yurdakul S, Ozdogan H, Kasapcopur O, et al. Behçet’s syndrome with juvenile onset: report of 44 patients. Clin Exp Rheumatol. 1993;S9(71):11.Google Scholar
  29. 29.
    Sungur GK, Hazirolan D, Yalvac I, et al. Clinical and demographic evaluation of Behçet disease among different paediatric age groups. Br J Ophthalmol. 2009;93:83–7.PubMedCrossRefGoogle Scholar
  30. 30.
    Yuksel Z, Schweizer JJ, Mourad-Baars PE, Sukhai RN, Mearin LM. A toddler with recurrent oral and genital ulcers. Clin Rheumatol. 2007;26:969–70.PubMedCrossRefGoogle Scholar
  31. 31.
    Ozdogan H. Behçet’s syndrome in children. In: Ansell BM, Bacon PA, Lie JT, Yazici H, editors. The vasculitides. London: Chapman & Hall; 1996. p. 416–24.Google Scholar
  32. 32.
    Mat MC, Goksugur N, Engin B, Yurdakul S, Yazici H. The frequency of scarring after genital ulcers in Behçet’s syndrome: a prospective study. Int J Dermatol. 2006;45:554–6.PubMedCrossRefGoogle Scholar
  33. 33.
    Kanski JJ, Shun-Shin GA. Systemic uveitis syndromes in childhood: an analysis of 340 cases. Ophthalmology. 1984;91:1247–52.PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Tugal-Tutkun I, Havrlikova K, Power WJ, Foster CS. Changing patterns in uveitis of childhood. Ophthalmology. 1996;103:375–83.PubMedCrossRefGoogle Scholar
  35. 35.
    Pivetti-Pezzi P. Uveitis in children. Eur J Ophthalmol. 1996;6:293–8.PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Soylu M, Ozdemir G, Anli A. Pediatric uveitis in southern Turkey. Ocul Immunol Inflamm. 1997;5:197–202.PubMedCrossRefGoogle Scholar
  37. 37.
    Sardar E, Dusser P, Rousseau A, Bodaghi B, Labetoulle M, Koné-Paut I. Retrospective study evaluating treatment decisions and outcomes of childhood uveitis not associated with Juvenile Idiopathic Arthritis. J Pediatr. 2017;186:131–7.e1.PubMedCrossRefPubMedCentralGoogle Scholar
  38. 38.
    Kitaichi N, Miyazaki A, Stanford MR, Iwata D, Chams H, Ohno S. Low prevalence of juvenile-onset Behcet’s disease with uveitis in East/South Asian people. Br J Ophthalmol. 2009;93:1428–30.PubMedCrossRefGoogle Scholar
  39. 39.
    Tugal-Tutkun I, Urgancioglu M. Childhood-onset uveitis in Behçet disease:a descriptive study of 36 cases. Am J Ophthalmol. 2003;136:1114–9.PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin Altunbas H, Urgancioglu M. Uveitis in Behçet disease: an analysis of 880 patients. Am J Ophthalmol. 2004;138:373–80.PubMedCrossRefPubMedCentralGoogle Scholar
  41. 41.
    Kesen MR, Goldstein DA, Tessler HH. Uveitis associated with pediatric Behçet disease in the american midwest. Am J Ophthalmol. 2008;146:819–27.e2.PubMedCrossRefPubMedCentralGoogle Scholar
  42. 42.
    Friling R, Kramer M, Snir M, Axer-Siegel R, Weinberger D, Mukamel M. Clinical course and outcome of uveitis in children. J AAPOS. 2005;9:379–82.PubMedCrossRefGoogle Scholar
  43. 43.
    Koné-Paut I, Yurdakul S, Bahabri SA, et al. Clinical features of Behçet’s disease in children: an international collaborative study of 86 cases. J Pediatr. 1998;132:721–5.PubMedCrossRefGoogle Scholar
  44. 44.
    Antar KA, Keiser HD, Peeva E. Relapsing arterial aneurysms in juvenile Behçet’s disease. Clin Rheumatol. 2005;24:72–5.PubMedCrossRefGoogle Scholar
  45. 45.
    Kutay V, Yakut C, Ekim H. Rupture of the abdominal aorta in a 13-year-old girl secondary to Behçet disease: a case report. J Vasc Surg. 2004;39:901–2.PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Beşbaş N, Ozyürek E, Balkanci F, et al. Behçet’s disease with severe arterial involvement in a child. Clin Rheumatol. 2002;21:176–9.PubMedCrossRefPubMedCentralGoogle Scholar
  47. 47.
    Akman-Demir G, Serdaroglu P, Tasci B. Clinical patterns of neurological involvement in Behcet’s disease: evaluation of 200 patients. The Neuro-Behcet Study Group. Brain. 1999;122:2171–82.PubMedCrossRefGoogle Scholar
  48. 48.
    Siva A, Kantarci OH, Saip S, et al. Behcet’s disease: diagnostic and prognostic aspects of neurological involvement. J Neurol. 2001;248:95–103.PubMedCrossRefPubMedCentralGoogle Scholar
  49. 49.
    Uluduz D, Kürtüncü M, Yapıcı Z, Seyahi E, Kasapçopur Ö, Özdoğan H, Saip S, Akman-Demir G, Siva A. Clinical characteristics of pediatric-onset neuro-Behçet disease. Neurology. 2011;77:1900–5.PubMedCrossRefGoogle Scholar
  50. 50.
    Koné-Paut I, Chabrol B, Riss JM, Mancini J, Raybaud C, Garnier JM. Neurologic onset of Behçet’s disease: a diagnostic enigma in childhood. J Child Neurol. 1997;12:237–41.PubMedCrossRefGoogle Scholar
  51. 51.
    Metreau-Vastel J, Mikaeloff Y, Tardieu M, Koné-Paut I, Tran TA. Neurological involvement in paediatric Behçet’s disease. Neuropediatrics. 2010;41:228–34.PubMedCrossRefGoogle Scholar
  52. 52.
    Ideguchi H, Suda A, Takeno M, Miyagi R, Ueda A, Ohno S, Ishigatsubo Y. Gastrointestinal manifestations of Behçet’s disease in Japan: a study of 43 patients. Rheumatol Int. 2014;34:851–6.PubMedCrossRefGoogle Scholar
  53. 53.
    Hatemi I, Hatemi G, Çelik AF. Gastrointestinal involvement in Behçet disease. Rheum Dis Clin N Am. 2018;44:45–64.CrossRefGoogle Scholar
  54. 54.
    Hung CH, Lee JH, Chen ST, Yang YH, Lin YT, Wang LC, Yu HH, Chiang BL. Young children with Behçet disease have more intestinal involvement. J Pediatr Gastroenterol Nutr. 2013;57:225–9.PubMedCrossRefGoogle Scholar
  55. 55.
    Yurdakul S, Tüzüner N, Yurdakul I, Hamuryudan V, Yazici H. Gastrointestinal involvement in Behçet’s syndrome: a controlled study. Ann Rheum Dis. 1996;55:208–10.PubMedPubMedCentralCrossRefGoogle Scholar
  56. 56.
    Tabata M, Tomomasa T, Kaneko H, Morikawa A. Intestinal Behçet’s disease: a case report and review of Japanese reports in children. J Pediatr Gastroenterol Nutr. 1999;29:477–81.PubMedCrossRefGoogle Scholar
  57. 57.
    Davatchi F, Sadegh Abdollahi B, Shahram F, et al. Validation of the international criteria for Behcet’s disease in Iran. Int J Rheum Dis. 2010;13:55–60.PubMedCrossRefGoogle Scholar
  58. 58.
    Zhou Q, Wang H, Schwartz DM, Stoffels M, Park YH, Zhang Y, et al. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease. Nat Genet. 2016;48:67–73.PubMedCrossRefGoogle Scholar
  59. 59.
    Aeschlimann FA, Batu ED, Canna SW, et al. A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease. Ann Rheum Dis. 2018;77:728–35.PubMedCrossRefGoogle Scholar
  60. 60.
    Lachmann HJ. Periodic fever syndromes. Best Pract Res Clin Rheumatol. 2017;31:596–609.PubMedCrossRefPubMedCentralGoogle Scholar
  61. 61.
    Theodoropoulou K, Vanoni F, Hofer M. Periodic fever, Aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome: a review of the pathogenesis. Curr Rheumatol Rep. 2016;18:18.PubMedCrossRefPubMedCentralGoogle Scholar
  62. 62.
    Adrovic A, Sahin S, Barut K, Kasapcopur O. Familial Mediterranean fever and periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: shared features and main differences. Rheumatol Int. 2018; Scholar
  63. 63.
    Esatoglu SN, Hatemi G, Salihoglu A, Hatemi I, Soysal T, Celik AF. A reappraisal of the association between Behçet’s disease, myelodysplastic syndrome and the presence of trisomy 8: a systematic literature review. Clin Exp Rheumatol. 2015;33(6 Suppl 94):S145–51.PubMedPubMedCentralGoogle Scholar
  64. 64.
    Saadoun D, Wechsler B, Desseaux K, Le Thi HD, Amoura Z, Resche-Rigon M, et al. Mortality in Behcet’s disease. Arthritis Rheum. 2010;62:2806–12.PubMedCrossRefPubMedCentralGoogle Scholar
  65. 65.
    Guillaume-Czitrom S, Berger C, Pajot C, Bodaghi B, Wechsler B, Kone-Paut I. Efficacy and safety of interferon-alpha in the treatment of corticodependent uveitis of paediatric Behcet’s disease. Rheumatology (Oxford). 2007;46:1570–3.CrossRefGoogle Scholar
  66. 66.
    Saurenmann RK, Levin AV, Rose JB, et al. Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis. Rheumatology (Oxford). 2006;45:982–9.CrossRefGoogle Scholar
  67. 67.
    Yasui K, Misawa Y, Shimizu T, Komiyama A, Kawakami T, Mizoguchi M. Thalidomide therapy for juvenile-onset entero-Behçet disease. J Pediatr. 2003;143:692–4.PubMedCrossRefPubMedCentralGoogle Scholar
  68. 68.
    Koné-Paut I. Behçet’s disease in children, an overview. Pediatr Rheumatol Online J. 2016;14:10.PubMedPubMedCentralCrossRefGoogle Scholar
  69. 69.
    Deitch I, Amer R, Tomkins-Netzer O, Habot-Wilner Z, Friling R, Neumann R, Kramer M. The effect of anti-tumor necrosis factor alpha agents on the outcome in pediatric uveitis of diverse etiologies. Graefes Arch Clin Exp Ophthalmol. 2018;256:801–8.PubMedCrossRefPubMedCentralGoogle Scholar
  70. 70.
    Kuemmerle-Deschner JB, Tzaribachev N, Deuter C, Zierhut M, Batra M, Koetter I. Interferon-alpha--a new therapeutic option in refractory juvenile Behçet’s disease with CNS involvement. Rheumatology (Oxford). 2008;47:1051–3.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Emire Seyahi
    • 1
  • Isabelle Koné-Paut
    • 2
  1. 1.Division of Rheumatology, Department of Internal Medicine, Istanbul University-CerrahpasaIstanbulTurkey
  2. 2.Department of Pediatric Rheumatology and CEREMAIAKremlin-Bicêtre Hospital, APHP, University of Paris Sud and UVSQ SaclayLe Kremlin BicêtreFrance

Personalised recommendations